More than 90% of patients have circulating antimitochondrial autoantibodies (AMAs) [7,8], and about 30% to 50% of patients with PBC also have antinuclear antibodies, including anti-gp210, anti-p62 and anti-sp100. Here, NUP210 is linked to primary biliary cholangitis.